SPORANOX 10MG/ML POR SOL 150ML

What is the maximum co-payment for SPORANOX?

If the insurance company contributes, the maximum co-payment is 205,98 Kč. The maximum pharmacy price is 1 582,15 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does SPORANOX have a counted co-payment set?

Yes, the medicine has a counted co-payment of 27,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

1 376,17 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe SPORANOX?

infectious diseases medicine
hematology and transfusion medicine, pediatric oncology and hematology
clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
otorhinolaryngology and head and neck surgery, pediatric otorhinolaryngology
specializované pracoviště – transplantační centrum

What is the composition of SPORANOX?

Itrakonazol (10 mg), neznámá látka s kódem 14223, koncentrovaná kyselina chlorovodíková, propylenglykol, solution hydroxidu sodného, dihydrát sodné soli sacharinu, neznámá látka s kódem 14542, neznámá látka s kódem 4321, karamel, čištěná voda (1 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to SPORANOX?

The medicine belongs to ATC group J02AC02 – ITRAKONAZOL. Medicines with the same active substance can be found here.

Who manufactures SPORANOX?

Janssen-Cilag s.r.o., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 30. 10. 2023. Production was terminated with effect from 30. 4. 2024. The manufacturer lists medicines with the following code as a potential substitute:

Note provided: Lék obtížně nahraditelný (lék v jiné lékové formě, případně jiná antimykotika) – dle uvážení lékaře.